Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress

Overview of attention for article published in BMC Cancer, February 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 36 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 23 publications that cite this research output.

23

The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.

Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer

Article in Frontiers in Oncology (April 2024)

Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan

Article in Neoplasia (December 2021)

Apple polyphenol phloretin complexed with ruthenium is capable of reprogramming the breast cancer microenvironment through modulation of PI3K/Akt/mTOR/VEGF pathways

Article in Toxicology and Applied Pharmacology (December 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.